TCT 741: Safety and Effectiveness of Left Atrial Appendage Occlusion According to CHA2DS2-VASc Scores from the SURPASS Study

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Medtronic; Boston Scientific Corporation; Edwards Lifesciences</li></ul>